Depomed to Present at Merriman Curhan Ford`s Investor Summit 2009

MENLO PARK, Calif.--(Business Wire)--
Depomed, Inc. (NASDAQ:DEPO) announced today that its president and chief
executive officer, Carl A. Pelzel will be presenting at Merriman Curhan Ford`s
6th annual Investor Summit in New York, NY on November 10, 2009 at 1:00 pm EST.

The company will be webcasting its presentation and interested parties can
access the live or archived presentation for up to 90 days on the company`s
website at www.depomed.com.

About Depomed

Depomed, Inc. is a specialty pharmaceutical company with one product candidate
through Phase 3 clinical development, another in Phase 3 clinical development,
two approved products on the market and other product candidates in its early
stage pipeline. Product candidate DM-1796 has completed Phase 3 clinical
development and has been licensed to Solvay Pharmaceuticals. A New Drug
Applications for DM-1796 is expected to be filed with the FDA in the first
quarter of 2010. Product candidate SeradaTM is in Phase 3 clinical development
for menopausal hot flashes. GLUMETZA(R) (metformin hydrochloride extended
release tablets) is approved for use in adults with type 2 diabetes and promoted
by Santarus, Inc. in the United States. Depomed formulates its products and
product candidates with its proven, proprietary Acuform(R) drug delivery
technology, which is designed to improve existing oral medications, allowing for
extended, controlled release of medications to the upper gastrointestinal tract.
Benefits of Acuform-enhanced pharmaceuticals include the convenience of
once-daily administration, improved treatment tolerability and enhanced
compliance and efficacy. Additional information about Depomed may be found on
its website, www.depomed.com.

About Merriman Curhan Ford

Merriman Curhan Ford (NASDAQ:MERR) is a financial services firm focused on
fast-growing companies and the institutions that invest in them. The company
offers high-quality investment banking, equity research, institutional services
and corporate & venture services, and specializes in five growth industry
sectors: CleanTech, Consumer, Media & Internet, Health Care, Natural Resources
and Technology. For more information, please go to www.mcfco.com.

Depomed, Inc.
Sheilah Serradell, 650-462-5900
sserradell@depomed.com

Copyright Business Wire 2009